Loading organizations...
Key people at The Mark Foundation for Cancer Research.
The Mark Foundation is a philanthropic organization accelerating breakthroughs in cancer science. It strategically provides grants to a global network of scientists, funding innovative research across various cancer types. Their approach drives transformative advancements in prevention, diagnosis, and treatment by empowering investigators and fostering collaborative scientific endeavors.
The foundation was established to address critical gaps in cancer research funding, stemming from a commitment to catalyze scientific discovery. It emerged with a clear mandate to support high-impact projects, building a framework designed to foster groundbreaking advancements. This foundational effort ensured vital research receives necessary resources to accelerate progress within the field.
The primary beneficiaries are cancer researchers and institutions globally, ultimately aiming to profoundly impact patients. By investing in diverse research portfolios and identifying emerging scientific leaders, The Mark Foundation seeks to radically transform patient outcomes. Its vision centers on advancing comprehensive scientific understanding and translating discoveries into effective clinical solutions for cancer eradication.
The Mark Foundation for Cancer Research has 7 tracked investments across 5 companies. The latest tracked deal is $75.0M Series C in Accent Therapeutics in January 2024.
Key people at The Mark Foundation for Cancer Research.